Get started
Author

Muhammad Ali Khan

Clinical efficacy of belzutifan in pre-treated renal cell carcinoma: A real world retrospective cohort benchmarked to LITESPARK-005.
2026 · Mousab Al Abbas, Muhammad Ali Khan, et al. · Journal of Clinical Oncology · 2
PDF
Abstract A176: Low utilization of the Decipher genomic classifier and oncologic outcomes in African American men with localized prostate cancer: A cancer-disparities analysis
2026 · Kaneez Zahra R. Khakwani, Muhammad Ali Khan, et al. · Cancer Epidemiology Biomarkers & Prevention
Differential quality of life (QoL) with novel hormonal therapy (NHT) in metastatic castration-sensitive prostate cancer (mCSPC): A network meta-analysis of randomized clinical trials.
2026 · Muhammad Uzair Sarfraz, Syed Arsalan Ahmed Naqvi, et al. · Journal of Clinical Oncology
Immune checkpoint inhibitor combinations in sarcomatoid metastatic clear cell renal cell carcinoma: A systematic review and meta-analysis.
2026 · Priya Kumar, Zaryab Bin Riaz, et al. · Journal of Clinical Oncology
Cardiovascular toxicity with androgen-receptor pathway inhibitors in metastatic prostate cancer: A meta-analysis of randomized trials.
2026 · Muhammad Hussnain Sadiq, Muhammad Uzair Sarfraz, et al. · Journal of Clinical Oncology
Impact of GLP1 receptor agonists on severity of prostate cancer at diagnosis: A propensity score weighted analysis.
2026 · Muhammad Ali Khan, Viraj R. Shah, et al. · Journal of Clinical Oncology
Comparative real-world survival and prescription patterns of darolutamide versus apalutamide in non-metastatic hormone-resistant prostate cancer.
2026 · Muhammad Umar Afzal, Lanyu Mi, et al. · Journal of Clinical Oncology
PDF
Works count: 7
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type